`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`SAMSUNGBIOEFPIS CoO., LTD.,
`Petitioner,
`
`Vv.
`
`REGENERON PHARMACEUTICALS,INC.,
`Patent Owner.
`
`Case IPR2023-00884
`
`U.S. Patent No. 11,253,572
`
`PETITIONER’S AMENDED POWER OF ATTORNEY
`
`
`
`Pursuant to 37 C.F.R. § 42.10, Petitioner Samsung Bioepis Co., Ltd. hereby
`
`amendsits powerof attorney to add attorney Richard Erwine as back-up counsel to
`
`transact all business before the Patent Trial & Appeal Board of the U.S. Patent and
`
`Trademark Office associated with the above-captioned /nter Partes Review of U.S.
`
`Backup Counsel
`Richard W. Erwine (Reg. No 41,737)
`Matthew A. Traupman(Reg. No.
`50,832)
`Elliot Choi (admitted pro hac vice)
`QUINN EMANUEL URQUHART
`& SULLIVAN, LLP
`51 Madison Ave., 22™ Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7322
`Fax: (212) 849-7100
`matthewtraupman@quinnemanuel.com
`elliotchoi@quinnemanuel.com
`
`Zachariah Summers (admitted pro hac
`vice)
`Sarah Cork (admitted pro hac vice)
`QUINN EMANUEL URQUHART
`& SULLIVAN, LLP
`865 S. Figueroa St., 10" Floor
`Los Angeles, California 90017
`General Tel: (213) 443-3000
`Fax: (213) 443-3100
`zachsummers@quinnemanuel.com
`
`_
`
`
`
`Patent No. 11,253,572:
`
`Lead Counsel
`
`RaymondN. Nimrod (Reg. No. 31,987)
`QUINN EMANUEL URQUHART
`& SULLIVAN, LLP
`51 Madison Ave., 22™ Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7322
`Fax: (212) 849-7100
`raynimrod@quinnemanuel.com
`
`
`
`
`
`
`
`
`
`
`
`Landon Andrew Smith (Reg. No.
`79,248)
`QUINN EMANUEL URQUHART
`& SULLIVAN, LLP
`300 W.6th Street
`Austin, TX 78701
`Tel: (737) 667-6100
`Fax: (737) 667-6110
`landonsmith@quinnemanuel.com
`
`
`
`The individual signing below hasthe authority to execute this document on
`
`behalf of Petitioner.
`
`By:
`
`Jungwook Kim
`Executive Vice President
`Samsung Bioepis Co., Ltd.
`76, Songdogyoyuk-ro, Yeonsu-gu,
`Incheon 21987, Republic of Korea
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing Petitioner’s Amended
`Mandatory Notice Pursuant to 37 C.F.R. § 42.10(b) was served on March 26, 2024,
`to
`the following Counsel for Petitioner via email
`to Regeneron-MoFo-
`IPR@mofo.com;
`Counsel
`for
`Biocon
`Biologics,
`Inc.
`at
`MYL_REG_IPR@rmmslegal.com;
`and Counsel
`for Celltrion,
`Inc.
`at
`lgreen@geminilaw.com,
`fchu@geminilaw.com,
`rcerwinski@geminilaw.com,
`azalcenstein@geminilaw.com, and bmorris@geminilaw.com.
`
`DATED: March 26, 2024
`
`Respectfully submitted,
`By /Raymond N. Nimrod/
`Raymond N. Nimrod (Reg. No. 31,987)
`raynimrod@quinnemanuel.com
`QUINN EMANUEL URQUHART
` & SULLIVAN, LLP
`51 Madison Ave., 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`
`4
`
`